| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.08 |